COXFA4L2 and nonpapillary renal cell carcinoma: An integrated multi‐omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in ccRCC [51].